Rethinking MRI Protocols for Pituitary Microadenomas: Prioritizing Non-Contrast Imaging for Safe Follow-Up
While still more sensitive for the primary diagnosis, the non-contrast MRI was able to visualize the majority of detected microadenomas, and significant growth was ruled out, thus supporting the case to omit gadolinium from follow-up imaging in stable cases. This may translate to lower costs and decreased patient risk from contrast-related hazards.
Authors
- Banafsheh Zeinali-Rafsanjani (ORCID: https://orcid.org/0000-0002-4815-0345)
- Fariba Zarei (ORCID: https://orcid.org/0000-0002-2654-5725)
- Abdemouhed Jalil
- Farideh Nematollahi
- Mahdi Saeedi-Moghadam (ORCID: https://orcid.org/0000-0002-6235-3632)
Institutions
- Shiraz University of Medical Sciences (IR)
Publication Details
- Journal
- Tomography
- Published
- 2025-09-12
- DOI
- https://doi.org/10.3390/tomography11090105
- Primary Topic
- Pituitary Gland Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shiraz University of Medical Sciences
- Shiraz University